Correction: Genetic variant SLC2A2 is associated with risk of cardiovascular disease - Assessing the individual and cumulative effect of 46 type 2 diabetes related genetic variants (PLoS ONE (2012) 7, 11 (e50418) DOI: 10.1371/journal.pone.0050418);Genetic Variant SCL2A2 Is Associated with Risk of Cardiovascular Disease - Assessing the Individual and Cumulative Effect of 46 Type 2 Diabetes Related Genetic Variants

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Borglykke, Anders ^a   Grarup, Niels ^b   Sparsø, Thomas ^b   Linneberg, Allan ^a   Fenger, Mogens ^c   Jeppesen, Jørgen ^a,b   Hansen, Torben ^b,d   Pedersen, Oluf ^b,e,f   Jørgensen, Torben ^a,b,g  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Mental Health Services CPH   (Denmark)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^e HAGEDORN RESEARCH INSTITUTE   (Denmark)

^f AARHUS UNIVERSITY   (Denmark)

^g AALBORG UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CELL FUNCTION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE REGISTRY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

EID: 84869769880     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/annotation/77e1d9b0-2b94-4a1b-95d5-4336258cecef     Document Type: Erratum

References (19)

1. Capewell S, O'Flaherty M, (2008) What explains declining coronary mortality? Lessons and warnings. Heart 94: 1105-1108.
2. Dent T (2010) Predicting the risk of coronary heart disease. II: The role of novel molecular biomarkers and genetics in estimating risk, and the future of risk prediction. Atherosclerosis. S0021-9150(10)00439-9 [pii];10.1016/j.atherosclerosis.2010.06.021 [doi].
3. Thanassoulis G, Vasan RS, (2010) Genetic cardiovascular risk prediction: will we get there? Circulation 122: 2323-2334 122/22/2323 [pii];10.1161/CIRCULATIONAHA.109.909309 [doi].
4. Balagopal PB, de Ferranti SD, Cook S, Daniels SR, Gidding SS, et al. (2011) Nontraditional risk factors and biomarkers for cardiovascular disease: mechanistic, research, and clinical considerations for youth: a scientific statement from the American Heart Association. Circulation 123: 2749-2769 CIR.0b013e31821c7c64 [pii];10.1161/CIR.0b013e31821c7c64 [doi].
5. Grarup N, Sparso T, Hansen T, (2010) Physiologic characterization of type 2 diabetes-related loci. Curr Diab Rep 10: 485-497 10.1007/s11892-010-0154-y [doi].
6. Pfister R, Barnes D, Luben RN, Khaw KT, Wareham NJ, et al. (2011) Individual and cumulative effect of type 2 diabetes genetic susceptibility variants on risk of coronary heart disease. Diabetologia 54: 2283-2287 10.1007/s00125-011-2206-5 [doi].
7. Bielinski SJ, Pankow JS, Folsom AR, North KE, Boerwinkle E, (2008) TCF7L2 single nucleotide polymorphisms, cardiovascular disease and all-cause mortality: the Atherosclerosis Risk in Communities (ARIC) study. Diabetologia 51: 968-970 10.1007/s00125-008-1004-1 [doi].
8. Paynter NP, Chasman DI, Pare G, Buring JE, Cook NR, et al. (2010) Association between a literature-based genetic risk score and cardiovascular events in women. JAMA 303: 631-637 303/7/631 [pii];10.1001/jama.2010.119 [doi].
9. Ridker PM, Cook NR, Cheng S, Erlich HA, Lindpaintner K, et al. (2003) Alanine for proline substitution in the peroxisome proliferator-activated receptor gamma-2 (PPARG2) gene and the risk of incident myocardial infarction. Arterioscler Thromb Vasc Biol 23: 859-863 10.1161/01.ATV.0000068680.19521.34 [doi];01.ATV.0000068680.19521.34 [pii].
10. Gerdes LU, Bronnum-Hansen H, Madsen M, Borch-Johnsen K, Jorgensen T, et al. (2000) Trends in selected biological risk factors for cardiovascular diseases in the Danish MONICA population, 1982-1992. J Clin Epidemiol 53: 427-434 S0895-4356(99)00193-6 [pii].
11. Tunstall-Pedoe H, (1985) Monitoring trends in cardiovascular disease and risk factors: the WHO "Monica" project. WHO Chron 39: 3-5.
12. Jorgensen T, Borch-Johnsen K, Thomsen TF, Ibsen H, Glumer C, et al. (2003) A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. Eur J Cardiovasc Prev Rehabil 10: 377-386 10.1097/01.hjr.0000096541.30533.82 [doi].
13. Andersen TF, Madsen M, Jorgensen J, Mellemkjaer L, Olsen JH, (1999) The Danish National Hospital Register- A valuable source of data for modern health sciences. Danish Medical Bulletin 46: 263-268.
14. Juel K, Helweg-Larsen K, (1999) The Danish registers of causes of death. Danish Medical Bulletin 46: 354-357.
15. Duesing K, Fatemifar G, Charpentier G, Marre M, Tichet J, et al. (2008) Strong association of common variants in the CDKN2A/CDKN2B region with type 2 diabetes in French Europids. Diabetologia 51: 821-826 10.1007/s00125-008-0973-4 [doi].
16. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, et al. (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42: 105-116 ng.520 [pii];10.1038/ng.520 [doi].
17. Igl W, Johansson A, Wilson JF, Wild SH, Polasek O, et al. (2010) Modeling of environmental effects in genome-wide association studies identifies SLC2A2 and HP as novel loci influencing serum cholesterol levels. PLoS Genet 6: e1000798. 10.1371/journal.pgen.1000798 [doi].
18. Glumer C, Jorgensen T, Borch-Johnsen K, (2003) Prevalences of diabetes and impaired glucose regulation in a Danish population: the Inter99 study. Diabetes Care 26: 2335-2340.
19. Ebrahim S, Beswick A, Burke M, Davey SG (2006) Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev CD001561. 10.1002/14651858.CD001561.pub2 [doi].